Skip to content

The Oncology Institute, Inc. TOI Balance Sheet Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$30.28M-9.8%$33.57M+21.4%$27.66M-8.7%$30.29M-23.8%$39.74M-20.0%
$232.43M+3.9%$223.62M+5.0%$212.95M+2.5%$207.82M+0.8%$206.17M-4.4%
$75.83M+18.8%$63.85M+12.0%$57.02M+18.2%$48.24M+10.2%$43.78M+1.8%
$116.86M+3.7%$112.75M+2.4%$110.09M+5.1%$104.79M-1.9%$106.82M-5.0%
$10.7M+0.1%$10.68M-0.3%$10.71M-1.3%$10.85M-2.4%$11.12M-6.5%
$7.23M0.0%$7.23M0.0%$7.23M0.0%$7.23M0.0%$7.23M0.0%
$10.3M-6.5%$11.02M-6.1%$11.73M-5.8%$12.45M-11.3%$14.04M-5.2%
$168.23M+2.2%$164.66M+0.6%$163.62M+2.4%$159.8M-2.6%$164M-5.0%
$47.65M+10.4%$43.17M+21.1%$35.63M+2.0%$34.93M+19.3%$29.29M+20.4%
$79.35M+11.8%$70.96M+8.2%$65.58M+1.2%$64.78M+8.8%$59.54M+14.0%
$78.61M+1.6%$77.4M+1.6%$76.2M+1.6%$75.02M+1.5%$73.89M-20.7%
$184.52M+2.3%$180.38M+2.5%$175.89M+4.2%$168.78M+6.2%$158.93M-6.0%
500M0.0%500M0.0%500M0.0%500M0.0%500M+6,249,900%
-$273.91M-0.9%-$271.42M-2.8%-$263.91M-6.7%-$247.41M-7.4%-$230.4M-9.3%
-$16.29M-3.6%-$15.72M-28.1%-$12.27M-36.6%-$8.99M-277%$5.07M+41.2%
$168.23M+2.2%$164.66M+0.6%$163.62M+2.4%$159.8M-2.6%$164M-5.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are The Oncology Institute, Inc.'s total assets?
The Oncology Institute, Inc. (TOI) holds $168.2M in total assets, up 2.6% year over year.
How much debt does The Oncology Institute, Inc. have?
The Oncology Institute, Inc. carries $104.9M in total debt against -$16.3M of shareholders' equity, a debt-to-equity ratio of 20.21.
How much cash does The Oncology Institute, Inc. have?
The Oncology Institute, Inc. holds $30.3M in cash and equivalents.
Can The Oncology Institute, Inc. cover its short-term obligations?
Its current ratio is 1.47 — current assets exceed current liabilities.
Where does The Oncology Institute, Inc.'s balance sheet data come from?
Every line is extracted from The Oncology Institute, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.